Full Text Journal Articles by
Author Livingstone Dogara

Advertisement

Find full text journal articles








Racial inequalities in access to care for young people living with pain due to sickle cell disease.

Baba Psalm Duniya Inusa, Eufemia Jacob, Livingstone Dogara, Kofi A Anie,

Lancet Child Adolesc Health (The Lancet. Child & adolescent health)
[2020, :]

Cited: 0 times

View full text PDF listing >>



Corrigendum to "Sickle cell disease clinical phenotypes in Nigeria: A preliminary analysis of the Sickle Pan Africa Research Consortium Nigeria database" [Blood Cells, Molecules and Diseases (2020) Start page-End page/202438].

Hezekiah Isa, Samuel Adegoke, Anazoeze Madu, Abdul-Aziz Hassan, Chinatu Ohiaeri, Reuben Chianumba, Biobele Brown, Emmanuel Okocha, Ngozi Ugwu, Ijeoma Diaku-Akinwumi, Titilope Adeyemo, Aisha Kuliya-Gwarzo, Livingstone Dogara, Haliru Lawal, Yohanna Tanko, Adama Ladu, Umar Kangiwa, Lilian Ekwem, Seyi Oniyangi, Tambi Wakama, Dominic Umoru, Olaniyi Olanrewaju, Norah Akinola, Uchenna Nnebe-Agumadu, Samuel Asala, Adekunle Adekile, John Olaniyi, Raphael Sangeda, , Obiageli Nnodu,

Blood Cells Mol Dis (Blood cells, molecules & diseases)
[2020, :102480]

Cited: 0 times

View full text PDF listing >>



Advertisement

Sickle cell disease clinical phenotypes in Nigeria: A preliminary analysis of the Sickle Pan Africa Research Consortium Nigeria database.

Hezekiah Isa, Samuel Adegoke, Anazoeze Madu, Abdul-Aziz Hassan, Chinatu Ohiaeri, Reuben Chianumba, Biobele Brown, Emmanuel Okocha, Ngozi Ugwu, Ijeoma Diaku-Akinwumi, Titilope Adeyemo, Aisha Kuliya-Gwarzo, Livingstone Dogara, Haliru Lawal, Yohanna Tanko, Adama Ladu, Umar Kangiwa, Lilian Ekwem, Seyi Oniyangi, Tambi Wakama, Domic Umoru, Olaniyi Olanrewaju, Norah Akinola, Uche Nnebe-Agumadu, Samuel Asala, Adekunle Adekile, John Olaniyi, Raphael Sangeda, Sickle Africa Data Coordinating Center SADaCC, Obiageli Nnodu,

BACKGROUND/OBJECTIVE:Sickle cell disease (SCD) is a monogenic disease with multiple phenotypic expressions. Previous studies describing SCD clinical phenotypes in Nigeria were localized, with limited data, hence the need to understand how SCD varies across Nigeria. METHOD:The Sickle Pan African Research Consortium (SPARCO) with a hub in Tanzania and collaborative sites ... Read more >>

Blood Cells Mol Dis (Blood cells, molecules & diseases)
[2020, 84:102438]

Cited: 0 times

View full text PDF listing >>



Differences in lung function between children with sickle cell anaemia from West Africa and Europe.

Michele Arigliani, Luigi Castriotta, Ramatu Zubair, Livingstone Gayus Dogara, Chiara Zuiani, Emma Raywood, Katy Vecchiato, Enrico Petoello, Ashel Dache Sunday, Sharon Ndoro, Mario Canciano Canciani, Atul Gupta, Paola Cogo, Baba Inusa,

INTRODUCTION:Lung function abnormalities are common in sickle cell anaemia (SCA) but data from sub-Saharan Africa are limited. We hypothesised that children with SCA from West Africa had worse lung function than their counterparts from Europe. METHODS:This prospective cross-sectional study evaluated spirometry and anthropometry in black African individuals with SCA (haemoglobin ... Read more >>

Thorax (Thorax)
[2019, 74(12):1154-1160]

Cited: 0 times

View full text PDF listing >>



Capacity building for inherited bleeding disorders in sub-Saharan Africa.

Johnny Mahlangu, Kibet Shikuku, Livingstone Gayus Dogara,

Blood Adv (Blood advances)
[2019, 3(Suppl 1):5-7]

Cited: 0 times

View full text PDF listing >>



Lung function impairment in pediatric patients with sickle cell anemia from Nigeria is associated with low steady state hemoglobin.

Michele Arigliani, Livingstone Gayus Dogara, Ramatu Zubair, Luigi Castriotta, Anna Pusiol, Chiara Zuiani, Paola Cogo, Baba Inusa,

Am J Hematol (American journal of hematology)
[2019, 94(3):E70-E71]

Cited: 0 times

View full text PDF listing >>



Utilising the 'Getting to Outcomes®' Framework in Community Engagement for Development and Implementation of Sickle Cell Disease Newborn Screening in Kaduna State, Nigeria.

Baba P D Inusa, Kofi A Anie, Andrea Lamont, Livingstone G Dogara, Bola Ojo, Ifeoma Ijei, Wale Atoyebi, Larai Gwani, Esther Gani, Lewis Hsu,

BACKGROUND:Sickle Cell Disease (SCD) has been designated by WHO as a public health problem in sub-Saharan Africa, and the development of newborn screening (NBS) is crucial to the reduction of high SCD morbidity and mortality. Strategies from the field of implementation science can be useful for supporting the translation of ... Read more >>

Int J Neonatal Screen (International journal of neonatal screening)
[2018, 4(4):33]

Cited: 0 times

View full text PDF listing >>



Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings.

Baba Psalm Duniya Inusa, Atoyebi Wale, Abdul Aziz Hassan, Tushar Idhate, Livingstone Dogara, Ifeoma Ijei, Yewen Qin, Kofi Anie, Juliana Olufunke Lawson, Lewis Hsu,

The multiple clinical benefits of hydroxycarbamide in sickle cell disease are supported by a large body of evidence. The maximum tolerated dose (MTD) is the regimen recommended by guidelines from a panel of National Heart, Lung, and Blood Institute (NHLBI) experts, but other dosage regimens have been used in babies ... Read more >>

F1000Res (F1000Research)
[2018, 7:]

Cited: 0 times

View full text PDF listing >>



Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings

Baba Psalm Duniya Inusa, Wale Atoyebi, Abdul Aziz Hassan, Tushar Idhate, Livingstone Dogara, Ifeoma Ijei, Yewen Qin, Kofi Anie, Juliana Olufunke Lawson, Lewis Hsu,

The multiple clinical benefits of hydroxycarbamide in sickle cell disease are supported by a large body of evidence. The maximum tolerated dose (MTD) is the regimen recommended by guidelines from a panel of National Heart, Lung, and Blood Institute (NHLBI) experts, but other dosage regimens have been used in babies ... Read more >>

()
[, :]

Cited: 1 time

View full text PDF listing >>



White Paper: Pathways to Progress in Newborn Screening for Sickle Cell Disease in Sub-Saharan Africa.

Lewis Hsu, Obiageli E Nnodu, Biobele J Brown, Furahini Tluway, Shonda King, Livingstone G Dogara, Crystal Patil, Sergey S Shevkoplyas, Guillaume Lettre, Richard S Cooper, Victor R Gordeuk, Bamidele O Tayo,

Sickle Cell Disease (SCD) is among the most common single-gene diseases in the world but evidence-based comprehensive health care has not been implemented where the highest prevalence of SCD occurs, in sub-Saharan Africa (SSA). It represents an urgent health burden, both in terms of mortality and morbidity with an estimated ... Read more >>

J Trop Dis Public Health (Journal of tropical diseases & public health)
[2018, 6(2):260]

Cited: 3 times

View full text PDF listing >>



Coexistence of JAK2 and BCR-ABL mutation in patient with myeloproliferative neoplasm.

Abdulaziz Hassan, Livingstone Gayus Dogara, Ahmadu Aliyu Babadoko, Sani Awwalu, Aisha Indo Mamman,

The World Health Organisation (WHO) classifies myeloproliferative neoplasm (MPN) into BCR-ABL positive chronic myeloid leukaemia (CML Ph(+)) and Ph(-) MPN. The JAK2 V617F mutation is specific for Ph(-) MPN and occurs in approximately 50% of primary myelofibrosis. Earlier reports suggest that the occurrence of JAK2 and BCR-ABL mutations are mutually ... Read more >>

Niger Med J (Nigerian medical journal : journal of the Nigeria Medical Association)
[2015, 56(1):74-76]

Cited: 9 times

View full text PDF listing >>





Advertisement

Disclaimer
0.7286 s